Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist’s Perspective
Diagnostics · 05.03.2025 · 15 (5) · 631
DOI: 10.3390/diagnostics15050631 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 05.03.2025. Verfasst von Konrad Steinestel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology and Molecular Pathology, Bundeswehrkrankenhaus Ulm, 89081 Ulm, Germany. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Advances in tissue-based biomarkers have significantly enhanced diagnostic and therapeutic approaches in NSCLC, enabling precision medicine strategies. This review provides a comprehensive analysis of the molecular pathologist’s practical approach to assessing NSCLC biomarkers across various specimen types (liquid biopsy, broncho–alveolar lavage, transbronchial biopsy/endobronchial ultrasound-guided biopsy, and surgical specimen), including challenges such as biological heterogeneity and preanalytical variability. We discuss the role of programmed death ligand 1 (PD-L1) immunohistochemistry in predicting immunotherapy response, the practice of histopathological tumor regression grading after neoadjuvant chemoimmunotherapy, and the application of DNA- and RNA-based techniques for detecting actionable molecular alterations. Finally, we emphasize the critical need for quality management to ensure the reliability and reproducibility of biomarker testing in NSCLC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pathology and Molecular Pathology, Bundeswehrkrankenhaus Ulm, 89081 Ulm, Germany.
ORCID-Profile: Konrad Steinestel
Zitieren
APA
Steinestel, K., & Arndt, A. (2025). Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist’s Perspective. Diagnostics, 15(5), 631. https://doi.org/10.3390/diagnostics15050631
Vancouver
Steinestel K, Arndt A. Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist’s Perspective. Diagnostics. 2025;15(5):631. doi:10.3390/diagnostics15050631
BibTeX
@article{Steinestel2025,
author = {Steinestel, Konrad and Arndt, Annette},
title = {Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist’s Perspective},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {5},
pages = {631},
doi = {10.3390/diagnostics15050631}
}
EUVIMED